Sarcoma Outcomes

Exceptional cancer care focuses on quality of life. Dr. Kane explains how the Sarcoma Center at Roswell Park treats the whole patient to achieve optimal outcomes.

Five-Year Survival, Soft Tissue Sarcoma, Stages I, II, III & IV
Cases Diagnosed (2004-2010)

 
    0 1 2 3 4 5
(n=89) RPCI stage I 100% 98.40% 98.40% 98.40% 98.40% 98.40%
(n=67) RPCI stage II 100% 94.50% 87.40% 84.80% 84.80% 84.80%
(n=64) RPCI stage III 100% 81.60% 73.70% 67.80% 62.30% 62.30%
(n=32) RPCI stage IV 100% 77% 54.20% 47.80% 47.80% 47.80%
  SEER stage I 100% 98.50% 97.40% 96.10% 94.90% 93.30%
  SEER stage II 100% 96.40% 90.60% 85.30% 82.50% 78.90%
  SEER stage III 100% 85.50% 71.90% 62.90% 56.80% 53.60%
  SEER stage IV 100% 50% 32.80% 24.50% 20.70% 18.50%

American Joint Commission on Cancer (AJCC) Stage I-IV Soft Tissue Sarcoma

Data source:
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (1973-2011 varying) - Linked To County Attributes - Total U.S., 1969-2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014 (updated 5/7/2014), based on the November 2013 submission.